# Avery Dennison Corp: Form 10-Q for the period ended Jul 1, 2017

- Company: [Avery Dennison Corp](/companies/avy.md) (CIK 8818)
- Form: 10-Q
- Filed: 2017-08-01
- Accepted by EDGAR: Aug 1, 2017, 15:44 ET
- Period: 2017-07-01
- Accession: 0001104659-17-048434
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/8818/000110465917048434/a17-13273_110q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/8818/000110465917048434/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2017-07-01.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Gross profit | 3 months, 2017-04-02 to 2017-07-01 | $452.6m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2017-01-01 to 2017-07-01 | $895.0m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2017-04-02 to 2017-07-01 | $276.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2017-01-01 to 2017-07-01 | $560.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 3 months, 2017-04-02 to 2017-07-01 | $16.2m | us-gaap:InterestExpense |
| Interest expense | 6 months, 2017-01-01 to 2017-07-01 | $32.9m | us-gaap:InterestExpense |
| Income tax | 3 months, 2017-04-02 to 2017-07-01 | $28.6m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2017-01-01 to 2017-07-01 | $52.3m | us-gaap:IncomeTaxExpenseBenefit |
| Diluted EPS | 3 months, 2017-04-02 to 2017-07-01 | $1.34 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2017-01-01 to 2017-07-01 | $2.59 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2017-04-02 to 2017-07-01 | $1.37 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2017-01-01 to 2017-07-01 | $2.64 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2017-04-02 to 2017-07-01 | 89,900,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2017-01-01 to 2017-07-01 | 90,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2017-01-01 to 2017-07-01 | $178.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2017-01-01 to 2017-07-01 | $66.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months, 2017-01-01 to 2017-07-01 | $76.2m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months, 2017-01-01 to 2017-07-01 | $70.3m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2017-07-01 | $209.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2017-07-01 | $2.21bn | us-gaap:AssetsCurrent |
| Total assets | at 2017-07-01 | $5.09bn | us-gaap:Assets |
| Current liabilities | at 2017-07-01 | $1.97bn | us-gaap:LiabilitiesCurrent |
| Current portion of debt | at 2017-07-01 | $444.0m | us-gaap:DebtCurrent |
| Shareholders' equity | at 2017-07-01 | $1.07bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 43,370 characters.

Management’s Discussion and Analysis of Financial Condition and Results of Operations, or MD&A, provides management’s views on our financial condition and results of operations, should be read in conjunction with the accompanying unaudited Condensed Consolidated Financial Statements and notes thereto, and includes the following sections:

|  |  |
| --- | ---: |
| Non-GAAP Financial Measures | 18 |
| Overview and Outlook | 19 |
| Analysis of Results of Operations for the Second Quarter | 20 |
| Results of Operations by Reportable Segment for the Second Quarter | 22 |
| Analysis of Results of Operations for the Six Months Year-to-Date | 24 |
| Results of Operations by Reportable Segment for the Six Months Year-to-Date | 25 |
| Financial Condition | 27 |
| Recent Accounting Requirements | 31 |

### NON-GAAP FINANCIAL MEASURES

We report our financial results in conformity with accounting principles generally accepted in the United States of America, or GAAP, and also communicate with investors using certain non-GAAP financial measures. These non-GAAP financial measures are not in accordance with, nor are they a substitute for or superior to, the comparable GAAP financial measures. These non-GAAP financial measures are intended to supplement the presentation of our financial results that are prepared in accordance with GAAP. Based upon feedback from investors and financial analysts, we believe that the supplemental non-GAAP financial measures we provide are useful to their assessments of our performance and operating trends, as well as liquidity.

Our non-GAAP financial measures exclude the impact of certain events, activities or strategic decisions. The accounting effects of these events, activities or decisions, which are included in the GAAP financial measures, may make it difficult to assess our underlying performance in a single period. By excluding the accounting effects, both positive and negative, of certain items (e.g., restructuring charges, legal settlements, certain effects of strategic transactions and related costs, losses from debt extinguishments, gains and losses from curtailment and settlement of pension obligations, gains or losses on sales of certain assets, and other items), we believe that we are providing meaningful supplemental information to facilitate an understanding of our core operating results and liquidity measures. These non-GAAP financial measures are used internally to evaluate trends in our underlying performance, as well as to facilitate comparison to the results of competitors for a single period. While some of the items we exclude from GAAP financial measures recur, they tend to be disparate in amount, frequency, or timing.

We use the following non-GAAP financial measures in this MD&A:

- *Sales change ex. currency* refers to the increase or decrease in sales excluding the estimated impact of foreign currency translation. The estimated impact of foreign currency translation is calculated on a constant currency basis, with prior period results translated at current period average exchange rates to exclude the effect of foreign currency fluctuations.
- *Organic sales change* refers to the increase or decrease in sales excluding the estimated impact of foreign currency translation, product line exits, acquisitions and divestitures, and, where applicable, an extra week in our fiscal year.

We believe that sales change ex. currency and organic sales change assist investors in evaluating the sales growth from the ongoing activities of our businesses and better enable them to evaluate our results from period to period.

- *Free cash flow* refers to cash flow from operations, less payments for property, plant and equipment, software and other deferred charges, plus proceeds from sales of property, plant and equipment, plus (minus) net proceeds from sales (purchases) of investments. We believe that free cash flow assists investors by indicating the amount of cash we have available for debt reductions, dividends, share repurchases, and acquisitions.
- *Operational working capital* refers to trade accounts receivable and inventories, net of accounts payable, and excludes cash and cash equivalents, short-term borrowings, deferred taxes, other current assets and other current liabilities, as well as net current assets or liabilities held-for-sale. We believe that operational working capital assists investors in assessing our working capital requirements because it excludes the impact of fluctuations attributable to our financing and other activities (which affect cash and cash equivalents, deferred taxes, other current assets, and other current liabilities) that tend to be disparate in amount, frequency, or timing, and that may increase the volatility of working capital as a percentage of sales from period to period. The items excluded from this measure are not significantly influenced by our day-to-day activities managed at the operating level and do not necessarily reflect the underlying trends in our operations.

18

### OVERVIEW AND OUTLOOK

### Net Sales

The factors impacting the reported sales change are shown in the table below:

|  | Three Months Ended July 1, 2017 | Six Months Ended July 1, 2017 |
| --- | ---: | ---: |
| Reported sales change | 6% | 6% |
| Foreign currency translation | 1 | 1 |
| Sales change ex. currency | 7% | 7% |
| Acquisitions/divestitures | (4) | (3) |
| Organic sales change(1) | 3% | 3% |

(1) Total may not sum due to rounding

In the three and six months ended July 1, 2017, net sales increased on an organic basis due to higher volume.

### Net Income

Net income increased approximately $64 million in the first six months of 2017 compared to the same period last year. Major factors affecting net income in the first six months of 2017 included:

Positive factors:

- Higher volume
- Prior year loss from settlement of pension obligations
- Benefits from productivity initiatives, including savings from restructuring actions, net of transition costs

Offsetting factors:

- Negative mix
- Higher employee-related costs
- Foreign currency translation

### Acquisitions

During the first six months of 2017, we completed three acquisitions (collectively, the “2017 Acquisitions”), none of which were material, individually or in the aggregate, to our unaudited Condensed Consolidated Financial Statements. Refer to Note 2, “Acquisitions,” to the unaudited Condensed Consolidated Financial Statements for more information.

### Cost Reduction Actions

#### 2015/2016 Actions

During the six months ended July 1, 2017, we recorded $13.6 million in restructuring charges, net of reversals, related to restructuring actions initiated during the third quarter of 2015 (“2015/2016 Actions”). These charges consisted of severance and related costs for the reduction of approximately 380 positions, lease cancellation costs, and asset impairment charges.

#### Impact of Cost Reduction Actions

We anticipate incremental savings, net of transition costs, from our 2015/2016 actions of approximately $45 million to $50 million in 2017. We estimate cash restructuring costs of approximately $35 million in 2017.

Restructuring charges were included in “Other expense, net” in the unaudited Condensed Consolidated Statements of Income. Refer to Note 9, “Cost Reduction Actions,” to the unaudited Condensed Consolidated Financial Statements for more information.

### Accounting Guidance Update

In the first quarter of 2017, we adopted an accounting guidance update that simplifies several aspects of the accounting for stock-based payment transactions. Refer to Note 1, “General,” to the unaudited Condensed Consolidated Financial Statements for more information.

### Free Cash Flow

*(In millions)*

|  | Six Months Ended July 1, 2017 | July 2, 2016 |
| --- | ---: | ---: |
| Net cash provided by operating activities | $178.3 | $216.0 |
| Purchases of property, plant and equipment | (66.5) | (61.3) |
| Purchases of software and other deferred charges | (14.9) | (6.1) |
| Proceeds from sales of property, plant and equipment | .2 | 3.2 |
| Purchases of investments, net | (4.1) | – |
| Free cash flow | $93.0 | $151.8 |

Free cash flow in the first six months of 2017 decreased compared to the same period last year primarily due to operational working capital improvements in the prior year, the benefit of which did not repeat in the current year, higher income tax payments, net of refunds, as well as higher capital and software expenditures and purchases of investments, net. These were partially offset by higher net income. Free cash flow in the first six months of 2017 also reflected the impact of our adoption of the accounting guidance described in “Accounting Guidance Update.”

### Outlook

Certain factors that we believe may contribute to results for 2017 are described below:

- We expect our net sales to increase by 7% to 8%.
- Assuming the continuation of foreign currency rates in effect during July 2017, we would expect foreign currency translation to reduce our pre-tax operating income by approximately $4 million.
- We expect our full year effective tax rate to be approximately 28%.
- We anticipate our capital and software expenditures to be approximately $215 million.
- We estimate pre-tax cash restructuring and certain acquisition-related transaction costs to total approximately $40 million.

### ANALYSIS OF RESULTS OF OPERATIONS FOR THE SECOND QUARTER

### Income before Taxes

*(Dollars in millions)*

|  | Three Months Ended July 1, 2017 | July 2, 2016 |
| --- | ---: | ---: |
| Net sales | $1,626.9 | $1,541.5 |
| Cost of products sold | 1,174.3 | 1,107.4 |
| Gross profit | 452.6 | 434.1 |
| Marketing, general and administrative expense | 276.7 | 269.2 |
| Interest expense | 16.2 | 15.4 |
| Other expense, net | 10.2 | 50.2 |
| Income before taxes | $149.5 | $99.3 |
| Gross profit margin | 27.8% | 28.2% |

#### Gross Profit Margin

Gross profit margin for the second quarter of 2017 decreased compared to the same period last year due to margin decline in the Industrial and Healthcare Materials reportable segment, driven by a program loss in personal care tapes and higher raw material input costs.

#### Marketing, General and Administrative Expense

Marketing, general and administrative expense increased in the second quarter of 2017 compared to the same period last year reflecting the impact of acquisitions and higher employee-related costs, partially offset by benefits from productivity initiatives, including savings from restructuring, net of transition costs.

#### Other Expense, net

*(In millions)*

| Other expense, net by type Restructuring charges: | Three Months Ended July 1, 2017 | July 2, 2016 |
| --- | ---: | ---: |
| Severance and related costs | $7.3 | $3.6 |
| Asset impairment charges and lease cancellation costs | .3 | 2.8 |
| Other items: |  |  |
| Transaction costs | 2.6 | 2.1 |
| Loss from settlement of pension obligations | – | 41.4 |
| Loss on sale of asset | – | .3 |
| Other expense, net | $10.2 | $50.2 |

Refer to Note 9, “Cost Reduction Actions,” to the unaudited Condensed Consolidated Financial Statements for more information regarding charges associated with restructuring.

Refer to Note 6, “Pension and Other Postretirement Benefits,” to the unaudited Condensed Consolidated Financial Statements for more information regarding loss from settlement of pension obligations.

### Net Income and Earnings per Share

*(Dollars in millions, except per share amounts)*

|  | Three Months Ended July 1, 2017 | July 2, 2016 |
| --- | ---: | ---: |
| Income before taxes | $149.5 | $99.3 |
| Provision for income taxes | 28.6 | 19.3 |
| Net income | $120.9 | $80.0 |
| Net income per common share | $1.37 | $.90 |
| Net income per common share, assuming dilution | 1.34 | .88 |
| Effective tax rate | 19.1% | 19.4% |

#### Provision for Income Taxes

The effective tax rate for the three months ended July 1, 2017 included $3.4 million of tax benefit from effective settlements of certain foreign tax examinations and changes in our judgment about tax filing positions in certain foreign jurisdictions as a result of new information gained from our interactions with tax authorities, as well as $3.1 million of tax benefit due to decreases in certain tax reserves, including interest and penalties, as a result of closing tax years.

The effective tax rate for the three months ended July 2, 2016 included $6.7 million of tax benefit from the release of valuation allowances against certain deferred tax assets in a foreign jurisdiction associated with a structural simplification approved by the tax authority; $5 million of tax benefit from changes in our judgment about tax filing positions in certain foreign jurisdictions as a result of new information gained from our interactions with tax authorities; and $.7 million of tax benefits due to decreases in certain tax reserves as a result of closing tax years.

Our effective tax rate can vary widely from quarter to quarter due to interim reporting requirements, the recognition of discrete events, and the timing of repatriation of foreign earnings. Refer to Note 11, “Taxes Based on Income,” to the unaudited Condensed Consolidated Financial Statements for further information.

### RESULTS OF OPERATIONS BY REPORTABLE SEGMENT FOR THE SECOND QUARTER

Operating income refers to income before interest and taxes.

### Label and Graphic Materials

*(In millions)*

|  | Three Months Ended July 1, 2017 | July 2, 2016 |
| --- | ---: | ---: |
| Net sales including intersegment sales | $1,139.6 | $1,080.5 |
| Less intersegment sales | (16.5) | (15.9) |
| Net sales | $1,123.1 | $1,064.6 |
| Operating income(1) | 148.0 | 138.3 |
| (1) Included costs associated with restructuring and transaction costs in both quarters. | $5.0 | $6.2 |

#### Net Sales

The factors impacting the reported sales change are shown in the table below:

|  | Three Months Ended July 1, 2017 |
| --- | ---: |
| Reported sales change | 6% |
| Foreign currency translation | 1 |
| Sales change ex. currency | 7% |
| Acquisitions | (4) |
| Organic sales change(1) | 2% |

(1) Total may not sum due to rounding

In the second quarter of 2017, net sales increased on an organic basis due to higher volume. Sales increased on an organic basis at low-single digit rates in North America, Western Europe, and emerging markets.

#### Operating Income

Operating income increased in the second quarter of 2017 compared to the same period last year due to higher volume and benefits from productivity initiatives, including savings from restructuring actions, net of transition costs, partially offset by the net impact of pricing and raw material costs, and higher employee-related costs.

### Retail Branding and Information Solutions

*(In millions)*

|  | Three Months Ended July 1, 2017 | July 2, 2016 |
| --- | ---: | ---: |
| Net sales including intersegment sales | $375.8 | $359.3 |
| Less intersegment sales | (.7) | (.8) |
| Net sales | $375.1 | $358.5 |
| Operating income(1) | 28.2 | 23.1 |
| (1) Included costs associated with restructuring in both quarters, and, in 2016, loss on sale of an asset and transaction costs related to sale of product line. | $2.8 | $2.4 |

22

#### Net Sales

The factors impacting the reported sales change are shown in the table below:

|  | Three Months Ended July 1, 2017 |
| --- | ---: |
| Reported sales change | 5% |
| Foreign currency translation | 1 |
| Sales change ex. currency | 6% |
| Organic sales change | 6% |

In the second quarter of 2017, net sales increased on an organic basis due to higher volume reflecting growth of both radio-frequency identification products and base apparel tickets and tags.

#### Operating Income

Operating income increased in the second quarter of 2017 primarily reflecting benefits from productivity initiatives, including savings from restructuring actions, net of transition costs, and higher volume, partially offset by higher employee-related costs.

### Industrial and Healthcare Materials

*(In millions)*

|  | Three Months Ended July 1, 2017 | July 2, 2016 |
| --- | ---: | ---: |
| Net sales including intersegment sales | $130.3 | $120.3 |
| Less intersegment sales | (1.6) | (1.9) |
| Net sales | $128.7 | $118.4 |
| Operating income(1) | 11.0 | 16.9 |
| (1)Included costs associated with transaction costs in 2017 and restructuring in 2016. | $2.4 | $.2 |

#### Net Sales

The factors impacting the reported sales change are shown in the table below:

|  | Three Months Ended July 1, 2017 |
| --- | ---: |
| Reported sales change | 9% |
| Foreign currency translation | 2 |
| Sales change ex. currency(1) | 10% |
| Acquisitions | (10) |
| Organic sales change | –% |

(1) Total may not sum due to rounding

In the second quarter of 2017, net sales were flat on an organic basis as volume was comparable to the prior year, with growth in industrial categories offset by an anticipated decline in healthcare categories.

#### Operating Income

Operating income decreased in the second quarter of 2017 compared to the same period last year due to the impact of the decline in healthcare categories, higher employee-related costs, and growth investments, partially offset by higher volume in industrial categories and benefits from productivity initiatives, including savings from restructuring actions, net of transition costs. The benefit of higher volume from acquired businesses was more than offset by integration and transaction costs related to acquisitions.

### ANALYSIS OF RESULTS OF OPERATIONS FOR THE SIX MONTHS YEAR-TO-DATE

### Income before Taxes

*(Dollars in millions)*

|  | Six Months Ended July 1, 2017 | July 2, 2016 |
| --- | ---: | ---: |
| Net sales | $3,199.0 | $3,027.0 |
| Cost of products sold | 2,304.0 | 2,170.3 |
| Gross profit | 895.0 | 856.7 |
| Marketing, general and administrative expense | 560.0 | 547.4 |
| Interest expense | 32.9 | 30.7 |
| Other expense, net | 16.7 | 55.8 |
| Income from continuing operations before taxes | $285.4 | $222.8 |
| Gross profit margin | 28.0% | 28.3% |

#### Gross Profit Margin

Gross profit margin for the first six months of 2017 decreased compared to the same period last year due to margin decline in the Industrial and Healthcare Materials reportable segment, driven by the program loss in personal care tapes and higher raw material input costs.

#### Marketing, General and Administrative Expense

Marketing, general and administrative expense increased in the first six months of 2017 compared to the same period last year reflecting the impact of acquisitions and higher employee-related costs, partially offset by benefits from productivity initiatives, including savings from restructuring, net of transition costs, and the favorable impact of foreign currency translation.

#### Other Expense, net

*(In millions)*

| Other expense, net by type Restructuring charges: | Six Months Ended July 1, 2017 | July 2, 2016 |
| --- | ---: | ---: |
| Severance and related costs | $13.0 | $8.8 |
| Asset impairment charges and lease cancellation costs | .3 | 3.2 |
| Other items: |  |  |
| Transaction costs | 3.4 | 2.1 |
| Loss from settlement of pension obligations | – | 41.4 |
| Loss on sale of asset | – | .3 |
| Other expense, net | $16.7 | $55.8 |

Refer to Note 9, “Cost Reduction Actions,” to the unaudited Condensed Consolidated Financial Statements for more information regarding costs associated with restructuring.

Refer to Note 6, “Pension and Other Postretirement Benefits,” to the unaudited Condensed Consolidated Financial Statements for more information regarding loss from settlement of pension obligations.

### Net Income and Earnings per Share

*(Dollars in millions, except per share amounts)*

|  | Six Months Ended July 1, 2017 | July 2, 2016 |
| --- | ---: | ---: |
| Income before taxes | $285.4 | $222.8 |
| Provision for income taxes | 52.3 | 53.2 |
| Net income | $233.1 | $169.6 |
| Net income per common share | $2.64 | $1.90 |
| Net income per common share, assuming dilution | 2.59 | 1.87 |
| Effective tax rate | 18.3% | 23.9% |

24

#### Provision for Income Taxes

The effective tax rate for the six months ended July 1, 2017 included $3.4 million of tax benefit from effective settlements of certain foreign tax examinations and changes in our judgment about tax filing positions in certain foreign jurisdictions as a result of new information gained from our interactions with tax authorities, as well as $4.6 million of tax benefit due to decreases in certain tax reserves, including interest and penalties, as a result of closing tax years. The effective tax rate for the six months ended July 1, 2017 also included a net benefit of $13.3 million related to our adoption of the accounting guidance update related to stock-based payments described in Note 1, “General.”

The accounting guidance update related to stock-based payments requires that the effect of excess tax benefits associated with stock-based payments be recognized in the income statement instead of in capital in excess of par value as was the case prior to our adoption of this guidance. Excess tax benefits are the effects of tax deductions in excess of compensation expenses recognized for financial accounting purposes. These benefits related to stock-based awards are generally generated as a result of stock price appreciation during the vesting period or between the time of grant and the time of exercise. We expect future excess tax benefits pursuant to this guidance to vary depending on the stock-based payments in future reporting periods. These excess tax benefits may cause variability in our future effective tax rate as they can fluctuate based on vesting and exercise activity, as well as our future stock price. The tax effect of the tax deductions in excess of compensation cost related to the exercise of nonqualified stock options and vesting of other stock-based compensation awards recognized in capital in excess of par value was $7.1 million for the six months ended July 2, 2016.

In addition, the effective tax rate for the six months ended July 1, 2017 compared to the same period last year reflects a decrease in tax expense related to repatriation of non-permanently reinvested earnings of certain foreign subsidiaries and favorable changes in the geographic mix of our income before taxes.

The effective tax rate for the six months ended July 2, 2016 included $6.7 million of tax benefit from the release of valuation allowances against certain deferred tax assets in a foreign jurisdiction associated with a structural simplification approved by the tax authority; $6 million of tax benefit from changes in our judgment about tax filing positions in certain foreign jurisdictions as a result of new information gained from our interactions with tax authorities; and $3.3 million of tax benefit due to decreases in certain tax reserves as a result of closing tax years.

Our effective tax rate can vary widely from quarter to quarter due to interim reporting requirements, the recognition of discrete events and the timing of repatriation of foreign earnings. Refer to Note 11, “Taxes Based on Income,” to the unaudited Condensed Consolidated Financial Statements for further information.

### RESULTS OF OPERATIONS BY REPORTABLE SEGMENT FOR THE SIX MONTHS YEAR-TO-DATE

Operating income refers to income before interest and taxes.

### Label and Graphic Materials

*(In millions)*

|  | Six Months Ended July 1, 2017 | July 2, 2016 |
| --- | ---: | ---: |
| Net sales including intersegment sales | $2,244.4 | $2,109.9 |
| Less intersegment sales | (31.7) | (32.7) |
| Net sales | $2,212.7 | $2,077.2 |
| Operating income(1) | 283.8 | 264.9 |
| (1)Included costs associated with restructuring and transaction costs in both years. | $7.2 | $8.3 |

#### Net Sales

The factors impacting the reported sales change are shown in the table below:

|  | Six Months Ended July 1, 2017 |
| --- | ---: |
| Reported sales change | 7% |
| Foreign currency translation | 1 |
| Sales change ex. currency | 8% |
| Acquisitions | (4) |
| Organic sales change | 4% |

25

In the first six months of 2017, net sales increased on an organic basis primarily due to higher volume. Net sales increased on an organic basis at mid-single digit rates in emerging markets and Western Europe. In North America, net sales increased modestly on an organic basis.

#### Operating Income

Operating income increased in the first six months of 2017 compared to the same period last year primarily reflecting higher volume and benefits from productivity initiatives, including savings from restructuring, net of transition costs, partially offset by mix and higher employee-related costs.

### Retail Branding and Information Solutions

*(In millions)*

|  | Six Months Ended July 1, 2017 | July 2, 2016 |
| --- | ---: | ---: |
| Net sales including intersegment sales | $743.5 | $719.7 |
| Less intersegment sales | (1.6) | (1.7) |
| Net sales | $741.9 | $718.0 |
| Operating income(1) | 54.8 | 44.6 |
| (1) Included costs associated with restructuring and transaction costs in both years, and loss on sale of an asset in 2016. | $6.6 | $5.6 |

#### Net Sales

The factors impacting the reported sales change are shown in the table below:

|  | Six Months Ended July 1, 2017 |
| --- | ---: |
| Reported sales change | 3% |
| Foreign currency translation | 1 |
| Sales change ex. currency | 4% |
| Organic sales change | 4% |

In the first six months of 2017, net sales increased on an organic basis due to higher volume reflecting growth in both radio-frequency identification products and base apparel tickets and tags.

#### Operating Income

Operating income increased in the first six months of 2017 compared to the same period last year reflecting benefits from productivity initiatives, including savings from restructuring actions, net of transition costs, and higher volume, partially offset by higher employee-related costs.

### Industrial and Healthcare Materials

*(In millions)*

|  | Six Months Ended July 1, 2017 | July 2, 2016 |
| --- | ---: | ---: |
| Net sales including intersegment sales | $247.6 | $236.2 |
| Less intersegment sales | (3.2) | (4.4) |
| Net sales | $244.4 | $231.8 |
| Operating income(1) | 23.8 | 32.5 |
| (1)Included costs associated with restructuring in both years and transaction costs in 2017. | $2.9 | $.5 |

26

#### Net Sales

The factors impacting the reported sales change are shown in the table below:

|  | Six Months Ended July 1, 2017 |
| --- | ---: |
| Reported sales change | 5% |
| Foreign currency translation | 2 |
| Sales change ex. currency | 7% |
| Acquisitions | (8) |
| Organic sales change | (1 ) % |

In the first six months of 2017, net sales decreased on an organic basis primarily due to lower volume, as growth in industrial categories was more than offset by the anticipated decline in healthcare categories.

#### Operating Income

Operating income decreased in the first six months of 2017 compared to the same period last year due to the impact of the decline in healthcare categories, higher employee-related costs, and growth investments, partially offset by higher volume in industrial categories and benefits from productivity initiatives, including savings from restructuring actions, net of transition costs. The benefit of higher volume from acquired businesses was more than offset by integration and transaction costs related to acquisitions.

### FINANCIAL CONDITION

### Liquidity

### Operating Activities

*(In millions)*

|  | Six Months Ended July 1, 2017 | July 2, 2016 |
| --- | ---: | ---: |
| Net income | $233.1 | $169.6 |
| Depreciation and amortization | 90.8 | 89.4 |
| Provision for doubtful accounts and sales returns | 19.8 | 21.3 |
| Net losses from asset impairments and sales/disposals of assets | .6 | 3.2 |
| Stock-based compensation | 13.2 | 14.1 |
| Loss from settlement of pension obligations | – | 41.4 |
| Other non-cash expense and loss | 28.1 | 24.1 |
| Changes in assets and liabilities and other adjustments | (207.3) | (147.1) |
| Net cash provided by operating activities | $178.3 | $216.0 |

For cash flow purposes, changes in assets and liabilities and other adjustments exclude the impact of foreign currency translation (discussed below in “Analysis of Selected Balance Sheet Accounts”).

During the first six months of 2017, cash flow from operating activities decreased compared to the same period last year primarily due to operational working capital improvements in the prior year, the benefit of which did not repeat in the current year, and higher income tax payments, net of refunds. These were partially offset by higher net income. In addition, in the first six months of 2017, operating activities reflected the impact of our adoption of the accounting guidance described above in “Accounting Guidance Update.”

### Investing Activities

*(In millions)*

|  | Six Months Ended July 1, 2017 | July 2, 2016 |
| --- | ---: | ---: |
| Purchases of property, plant and equipment | $(66.5) | $(61.3) |
| Purchases of software and other deferred charges | (14.9) | (6.1) |
| Proceeds from sales of property, plant and equipment | .2 | 3.2 |
| Purchases of investments, net | (4.1) | – |
| Payments for acquisitions, net of cash acquired, and investments in businesses | (300.9) | – |
| Net cash used in investing activities | $(386.2) | $(64.2) |

27

#### Capital and Software Spending

During the first six months of 2017, we invested in new equipment to support growth in Asia, Europe, and North America, and to improve manufacturing productivity. During the first six months of 2016, we invested in new equipment to support growth, primarily in Asia, and to improve manufacturing productivity.

During the first six months of 2017, we invested in information technology primarily associated with enterprise resource planning system implementations in North America, Asia, and Europe. During the first six months of 2016, we invested in information technology primarily associated with enterprise resource planning system implementations in North America and Europe.

#### Payments for Acquisitions

During the first six months of 2017, the aggregate payments for acquisitions, net of cash acquired, was approximately $300 million, which we funded through cash and existing credit facilities.

Refer to Note 2, “Acquisitions,” to the unaudited Condensed Consolidated Financial Statements for more information.

### Financing Activities

*(In millions)*

|  | Six Months Ended July 1, 2017 | July 2, 2016 |
| --- | ---: | ---: |
| Net (decrease) increase in borrowings (maturities of three months or less) | $(159.5) | $104.6 |
| Additional long-term borrowings | 526.6 | – |
| Repayments of long-term debt | (1.5) | (1.2) |
| Dividends paid | (76.2) | (69.6) |
| Share repurchases | (70.3) | (160.1) |
| Proceeds from exercises of stock options, net | 17.5 | 41.4 |
| Tax withholding for and excess tax benefit from stock-based compensation, net | (20.0) | (8.4) |
| Net cash provided by (used in) financing activities | $216.6 | $(93.3) |

#### Borrowings and Repayment of Debt

Given the seasonality of our cash flow from operating activities, during the first six months of 2017 and 2016, our commercial paper borrowings were used to fund share repurchase activity, dividend payments, and capital expenditures.

In March 2017, we issued €500 million of senior notes, due March 2025. The senior notes bear an interest rate of 1.25% per year, payable annually in arrears. The net proceeds from the offering, after deducting underwriting discounts and estimated offering expenses, were $526.6 million (€495.5 million), a portion of which was used to repay commercial paper borrowings that we used to finance a portion of our acquisition of Mactac in August 2016. During the second quarter of 2017, we used the remainder for general corporate purposes, including acquisitions.

Refer to Note 5, “Debt,” and Note 2, “Acquisitions,” to the unaudited Condensed Consolidated Financial Statements for more information.

#### Dividend Payments

We paid dividends of $.86 per share in the first six months of 2017 compared to $.78 per share in the same period last year. In April 2017, we increased our quarterly dividend to $.45 per share, representing an increase of approximately 10% from our previous dividend rate of $.41 per share.

#### Share Repurchases

During the first six months of 2017, we repurchased .9 million shares of our common stock at an aggregate cost of $70.3 million. During the first six months of 2016, we repurchased 2.4 million shares of our common stock at an aggregate cost of $160.1 million.

In April 2017, our Board of Directors (“Board”) authorized the repurchase of shares of our common stock with a fair market value of up to $650 million, exclusive of any fees, commissions or other expenses related to such purchases and in addition to any amount outstanding under our previous Board authorization. Our Board repurchase authorizations remain in effect until shares in the respective amount authorized thereunder have been repurchased.

As of July 1, 2017, shares of our common stock in the aggregate amount of approximately $685 million remained authorized for repurchase under our outstanding Board authorizations.

#### Tax Withholding for and Excess Tax Benefit from Stock-Based Compensation, Net

During the first six months of 2017, tax withholding for and excess tax benefit from stock-based compensation, net, reflected the impact of our adoption of the previously described accounting guidance update. Refer to “Accounting Guidance Update” above for more information.

### Analysis of Selected Balance Sheet Accounts

#### Long-lived Assets

In the six months ended July 1, 2017, property, plant and equipment, net, increased by approximately $103 million to $1.02 billion, which primarily reflected the preliminary valuation of property, plant and equipment from the 2017 Acquisitions of approximately $65 million.

In the six months ended July 1, 2017, goodwill increased by approximately $157 million to $950.4 million, which reflected the preliminary valuation of goodwill associated with the 2017 Acquisitions, purchase price allocation adjustments associated with the acquisition of Mactac completed in August 2016, and the impact of foreign currency translation.

In the six months ended July 1, 2017, other intangibles resulting from business acquisitions, net, increased by approximately $101 million to $168.1 million, which reflected the preliminary valuation of other intangibles from the 2017 Acquisitions and the impact of foreign currency translation, partially offset by current year amortization expense.

Refer to Note 4, “Goodwill and Other Intangibles Resulting from Business Acquisitions,” and Note 2, “Acquisitions,” to the unaudited Condensed Consolidated Financial Statements for more information.

In the six months ended July 1, 2017, other assets increased by approximately $18 million to $420.6 million, which reflected an increase in the cash surrender value of our corporate-owned life insurance policies and the impact of foreign currency translation, partially offset by amortization expense related to software and other deferred charges, net of purchases.

#### Shareholders’ Equity Accounts

In the six months ended July 1, 2017, the balance of our shareholders’ equity increased by approximately $144 million to $1.07 billion, which primarily reflected net income, the use of treasury shares to settle stock-based awards and fund contributions to our U.S. defined contribution plan, and the impact of foreign currency translation. These increases were partially offset by dividend payments and share repurchases.

### Impact of Foreign Currency Translation

*(In millions)*

|  | Six Months Ended July 1, 2017 |
| --- | ---: |
| Change in net sales | $(31) |
| Change in net income | (4) |

International operations generated approximately 75% of our net sales during the six months ended July 1, 2017. Our future results are subject to changes in political and economic conditions in the regions in which we operate and the impact of fluctuations in foreign currency exchange and interest rates.

The unfavorable impact of foreign currency translation on net sales in the first six months of 2017 compared to the same period last year was primarily related to euro-denominated sales and sales in China, partially offset by sales in Brazil.

### Effect of Foreign Currency Transactions

The impact on net income from transactions denominated in foreign currencies is largely mitigated because the costs of our products are generally denominated in the same currencies in which they are sold. In addition, to reduce our income and cash flow exposure to transactions in foreign currencies, we enter into foreign exchange forward, option and swap contracts where available and appropriate. We also utilize certain foreign currency denominated debt to mitigate foreign currency exposure related to our investment in foreign operations.

### Analysis of Selected Financial Ratios

We utilize the financial ratios discussed below to assess our financial condition and operating performance.

#### Working Capital and Operational Working Capital Ratios

Working capital (current assets minus current liabilities), as a percentage of annualized net sales, was 3.7% in the first six months of 2017 compared to 5.8% in the first six months of 2016 primarily driven by an increase in short-term borrowings and current portion of long-term debt and capital leases, partially offset by increases in trade accounts receivable and inventories, net.

Operational working capital, as a percentage of annualized net sales, reconciled with working capital below, was 12.9% in the first six months of 2017 compared to 11.3% in the first six months of 2016 primarily driven by the impact of acquisitions. Our objective is to minimize our investment in operational working capital, as a percentage of annualized net sales, to maximize cash flow and return on investment.

*(Dollars in millions)*

|  | Six Months Ended July 1, 2017 | July 2, 2016 |
| --- | ---: | ---: |
| (A) Working capital | $237.4 | $350.3 |
| Reconciling items: |  |  |
| Cash and cash equivalents | (209.4) | (216.1) |
| Assets held for sale | (8.3) | (4.4) |
| Other current assets | (235.5) | (169.6) |
| Short-term borrowings and current portion of long-term debt and capital leases | 444.0 | 199.0 |
| Accrued payroll and employee benefits and other current liabilities | 597.5 | 525.3 |
| (B) Operational working capital | $825.7 | $684.5 |
| (C) Annualized net sales (year-to-date sales, multiplied by two) | $6,398.0 | $6,054.0 |
| Working capital, as a percentage of annualized net sales (A) ÷ (C) | 3.7% | 5.8% |
| Operational working capital, as a percentage of annualized net sales (B) ÷ (C) | 12.9% | 11.3% |

#### Accounts Receivable Ratio

The average number of days sales outstanding, calculated using the two-quarter average trade accounts receivable balance divided by the average daily sales for the first six months, was 64 days in the first six months of 2017 compared to 62 days in the first six months of 2016. The increase in the average number of days sales outstanding from the prior year primarily reflected the timing of collections, as well as the impact of acquisitions and the impact of foreign currency translation.

#### Inventory Ratio

Average inventory turnover, calculated using the annualized cost of sales (cost of sales for the first six months, multiplied by two) divided by the two-quarter average inventory balance, was 7.7 in the first six months of 2017 compared to 8.3 in the first six months of 2016. The decrease in the current year average inventory turnover primarily reflected the impact of acquisitions, as well as the timing of inventory purchases.

#### Accounts Payable Ratio

The average number of days payable outstanding, calculated using the two-quarter average accounts payable balance divided by the average daily cost of products sold for the first six months, was 73 days in the first six months of 2017 compared to 72 days in the first six months of 2016. The increase in average number of days payable outstanding from the prior year primarily reflected the timing of vendor payments, the impact of foreign currency translation, and the impact of acquisitions.

### Capital Resources

Capital resources include cash flows from operations, cash and cash equivalents and debt financing. At July 1, 2017, we had cash and cash equivalents of $209.4 million held in accounts at third-party financial institutions.

Our cash balances are held in numerous locations throughout the world. At July 1, 2017, the majority of our cash and cash equivalents was held by our foreign subsidiaries.

To meet U.S. cash requirements, we have several cost-effective liquidity options available. These options include borrowing funds at reasonable rates, including commercial paper, borrowings from foreign subsidiaries, and repatriating foreign earnings. However, if we were to repatriate incremental foreign earnings, we may be subject to additional taxes in the U.S.

Our $700 million revolving credit facility (the “Revolver”) contains financial covenants requiring that we maintain specified ratios of total debt and interest expense in relation to certain measures of income. As of July 1, 2017 and December 31, 2016, we were in compliance with our financial covenants.

In March 2017, we issued €500 million of senior notes, due March 2025. The senior notes bear an interest rate of 1.25% per year, payable annually in arrears. Refer to Note 5, “Debt,” to the unaudited Condensed Consolidated Financial Statements for more information.

We anticipate using commercial paper borrowings to fund the repayment of $250 million of senior notes maturing in October 2017.

We are exposed to financial market risk resulting from changes in interest and foreign currency rates, and to possible liquidity and credit risks of our counterparties.

#### Capital from Debt

Our total debt increased by approximately $428 million in the first six months of 2017 to $1.72 billion, primarily reflecting the issuance of senior notes in March 2017. Refer to “Financing Activities” above for more information.

Credit ratings are a significant factor in our ability to raise short- and long-term financing. The credit ratings assigned to us also impact the interest rates paid and our access to commercial paper, credit facilities, and other borrowings. A downgrade of our short-term credit ratings could impact our ability to access the commercial paper markets. If our access to commercial paper markets were to become limited, the Revolver and our other credit facilities would be available to meet our short-term funding requirements, if necessary. When determining a credit rating, we believe that rating agencies primarily consider our competitive position, business outlook, consistency of cash flows, debt level and liquidity, geographic dispersion and management team. We remain committed to maintaining an investment grade rating.

### Off-Balance Sheet Arrangements, Contractual Obligations, and Other Matters

Refer to Note 15, “Commitments and Contingencies,” to the unaudited Condensed Consolidated Financial Statements.

### RECENT ACCOUNTING REQUIREMENTS

Refer to Note 17, “Recent Accounting Requirements,” to the unaudited Condensed Consolidated Financial Statements.

## Market risk

As filed, 162 characters.

There have been no material changes to the information provided in Part II, Item 7A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2016.

## Controls and procedures

As filed, 3,083 characters.

### Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(f)) that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding the required disclosure.

In designing and evaluating the disclosure controls and procedures, we recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Our disclosure controls system is based upon a global chain of financial and general business reporting lines that converge in our headquarters in Glendale, California. As required by SEC Rule 13a-15(b), we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the quarter covered by this report. Based on the foregoing, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of such time to provide reasonable assurance that information was recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information was accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding the required disclosure.

### Changes in Internal Control Over Financial Reporting

We periodically assess our internal control environment. During 2014, we began a phased implementation of a new transactional system in our Retail Branding and Information Solutions reportable segment that is expected to continue through 2021. Processes affected by this implementation include order management, pricing, shipping, general accounting, manufacturing and planning. Where appropriate, we are reviewing related internal controls and making changes. Other than this implementation, there have been no changes in our internal control over financial reporting during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. We are currently in the process of reviewing our internal control structure related to businesses acquired in 2017. We will make any necessary changes as we integrate these acquired businesses into our overall process of internal control over financial reporting.

## Risk factors

As filed, 163 characters.

There have been no material changes to the risk factors included in Part I, Item 1A, of our Annual Report on Form 10-K for the fiscal year ended December 31, 2016.

Filed Aug 1, 2017.
Source: SEC EDGAR, the filing index for accession 0001104659-17-048434. Last ingested by Listed: Nov 10, 2026, 16:39 ET. No prices; not investment advice.
